Bioactivity | N9-Isopropylolomoucine is a mitotic cyclin dependent kinase (CDK) inhibitor. N9-Isopropylolomoucine targets CCNB 1/CDK1 and can be used for cancer research[1]. |
CAS | 158982-15-1 |
Formula | C17H22N6O |
Molar Mass | 326.40 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Kerry L., et al. Biomarkers indicative of prostate cancer and treatment thereof. Patent. WO2018187478 |